<DOC>
	<DOCNO>NCT02209519</DOCNO>
	<brief_summary>Male partner womoen recurrent bacteria vaginosis randomize treatment metronidazole placebo compare rate recurrent BV woman</brief_summary>
	<brief_title>Randomized Controlled Trial Treatment Male Partners Women With BV</brief_title>
	<detailed_description>This study perform phase III randomize , double-blinded trial evaluate efficacy 1 ) metronidazole 500 mg PO BID 7 day versus 2 ) placebo capsule alone treatment male sexual partner woman recurrent BV . The primary outcome rate recurrent BV two group . Although phase III study carefully monitor potential toxicity male since currently standard care treat male indication . Women symptomatic BV define Amsel criterion 1 evidence STD invite participate . Inclusion criterion woman least 18 year age , heterosexual , symptoms vaginal odor and/or discharge , meet modify clinical ( Amsel ) criterion BV ( must vaginal pH &gt; 4.5 , positive whiff test , clue cell eligible ) , enrollment Nugent score 7 great , history 2 episode BV previous year . She must regular current sex partner would willing participate . We exclude woman recurrent BV great 3 year well woman fail previous treatment study since likely woman recurrent BV result relapse BV biofilm oppose reinfection . Follow-up visit conduct day 21 , 8 16 week . At follow-up visit , questionnaire administer , diary review , pelvic examination conduct specimen ( Gram stain , Amsel criterion , G vaginalis culture detection novel organism ) obtain do enrollment visit . Participants ask return medication package , standard way assess adherence regimen . Cure ascertain use clinical criterion BV Amsel 1 well Nugent score system 16 . The persistence disappearance specific organism analyze relationship standard definition cure . Women fail initial therapy recurrence symptomatic BV course study re-treated 7 day metronidazole drop study time . Any woman find positive screen test gonorrhea chlamydia treat appropriately instructed notify partner need treat . Women intercurrent vaginal yeast infection , may occur , treated oral fluconazole continue study . Women positive culture trichomonas drop study male partner require treatment metronidazole . Male Study Procedures Males refer female sexual partner see within 48 hour enrollment female . Males consent asked behavioral historical question use gender appropriate questionnaire , special emphasis number current sexual partner . A couple verification screen tool utilize certain current sexual partners48 . The confidentiality answer emphasize . They examine urethral swab specimen obtain use G vaginalis culture archive . Following swab , two external swab coronal sulcus 10 ml first void urine specimen obtain . These specimen also use G vaginalis culture archive possible use detection novel organism . The urine also use NAATS N gonorrhoeae C trachomatis determine presence absence Gardnerella biofilm24 . They randomize one two treatment arm : 1 . Metronidazole 500 mg PO twice day 7 day . 2 . Placebo capsule PO twice day 7 day . Both arm also contain instruction sheet metronidazole .</detailed_description>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Female 1 . At least 18 year age ( 19 year age Alabama due State law ) 2 . Sexual partner female meet study eligibility 3 . Willingness provide informed consent 4 . Willingness abstain sexual intercourse use condom { study } 5 . Willingness abstain alcohol first week study Male 1 . At least 18 year age ( 19 year age Alabama due State law ) 2 . Heterosexual regular partner 3 . History 2 episode BV previous 12 month 4 . Symptoms BV include vaginal discharge and/or odor 5 . Positive Amsel criterion BV include vaginal pH &gt; 4.5 , positive whiff test , presence clue cell 6 . Willingness provide informed consent 7 . Willingness abstain sexual intercourse use condom { study } 8 . Willingness abstain alcohol first week study Exclusion criterion ( gender ) 1 . Allergy metronidazole 2 . Failure male partner keep appointment see within 48 hour 3 . Pregnant breast feeding ( female ) 4 . HIV chronic disease opinion investigator would interfere ability participate study 5 . Subject require concurrent lithium , coumadin , dilantin , antabuse 6 . Presence trichomonas wet prep vaginal fluid ( female ) 7 . Women history recurrent BV &gt; 3 year woman fail previous treatment study BV</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>bacterial vaginosis</keyword>
	<keyword>recurrence</keyword>
	<keyword>male partner</keyword>
</DOC>